Robert Sims, Ph.D.

Robert Sims, Ph.D.

Chief Scientific Officer, Co-Founder

EDUCATION
B.S., Microbiology, University of Texas at Austin
Ph.D., Cellular and Molecular Biology, University of Texas at Austin

PREVIOUS EXPERIENCE
Third Rock Ventures
Constellation Pharmaceuticals

Robert’s Flare characteristics: Fostering communication and collaboration while having a blast.

With 20+ years of experience in the transcription field, including 10+ years in the drug discovery of gene control, Robert is passionate about working with diverse and talented teams to discover and develop novel transcription factor medicines.

As a founding scientist of Constellation Pharmaceuticals, he feels fortunate to have experienced and contributed to nearly all aspects of company creation— from concept to becoming a public company, with multiple programs in clinical development. While at Constellation, Robert led the discovery and translational efforts for Pelabresib, a BET bromodomain inhibitor now in phase 3 clinical development for the treatment of myelofibrosis.

While trying to keep up with his three boys and lovely wife Ashley, Robert is cultivating an emerging Sims family garage rock band, playing whatever instrument they let him (guitar, bass, or drums).

WHAT MAKES YOU EXCITED TO ‘BRING IT’ EVERY DAY AT WORK?

What a team! And love the science, potential for patients, and opportunity to build a special company.

WHAT ENERGY COMES TO MIND IN DESCRIBING THE FLARE TEAM?

Gravitational - there is a tangible gravity to the quality and talent of our people.

 

This links to an external website.

Continue